TCTMD

Talking Points

Science EN ↓ 208 episodes

A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.06f763f0-76e5-11f0-bb7c-8557ae1d8a8b

Author

TCTMD

Episodes

Episode 155: Two DCBs Go Head to Head in De Novo CAD 25.08.2022 12:14

C. Michael Gibson and Wan Azman Wan Ahmad discuss a sirolimus-versus a paclitaxel-coated balloon in de novo coronary lesions.

Episode 154: The EMPEROR-Preserved Trial 10.08.2022 5:14

C. Michael Gibson and Stefan Anker discuss the effects of empagliflozin on CV death and HF hospitalizations in patients with HFpEF, with and without diabetes.

Episode 153: iFR-SWEDEHEART at 5 Years 03.08.2022 6:30

C. Michael Gibson and Matthias Götberg review 5-year findings after iFR- versus FFR-guided PCI.

Episode 152: PRONOUNCE: Prostate Cancer Drugs and CVD 20.07.2022 10:24

Renato Lopes and C. Michael Gibson discuss PRONOUNCE comparing the cardiovascular safety of degarelix vs. leuprolide in patients with advanced prostate cancer and CVD.

Episode 151: Stopping Amputation Post-revascularization: Novel Data in Mitigation of Thrombosis Risk 06.07.2022 9:01

Desai and Anahita Dua discuss highlights from a CME program on reducing thrombosis risks in patients with PAD post-revascularization. Claim credit: https://bit.ly/3QTpBt6. Supported by an educational grant from Janssen Scientific Affairs, LLC.

Episode 150: The TOMAHAWK Trial 06.07.2022 4:26

C. Michael Gibson and Steffen Desch discuss whether immediate angiography is warranted after out-of-hospital cardiac arrest.

Episode 149: The OPTIMUM Trial 22.06.2022 5:23

C. Michael Gibson and David Kandzari discuss PCI outcomes among patients at prohibitive risk for CABG.

Episode 148: The MASTER DAPT Trial 08.06.2022 9:00

C. Michael Gibson and Marco Valgimigli discuss dual antiplatelet therapy after coronary stenting in high-bleeding-risk patients.

Episode 147: The EROSION III Trial 01.06.2022 12:15

C. Michael Gibson, Haibo Jia, and Jingbo Hou discuss whether OCT guidance could cut stent use in STEMI without plaque rupture.

Episode 146: The LIFE Trial 18.05.2022 8:15

C. Michael Gibson and Douglas Mann discuss sacubitril/valsartan in patients with advanced HFrEF.

Episode 145: PRAGUE 17: LAA Closure vs DOACs 04.05.2022 11:46

C. Michael Gibson and Pavel Osmancik review 3-year results with LAA closure versus a DOAC for patients with atrial fibrillation.

Episode 144: MASTER DAPT: High-Risk Patients 20.04.2022 6:49

C. Michael Gibson and Pieter C. Smits review outcomes in high-bleeding-risk patients also at high risk for thrombotic events who were randomized to abbreviated DAPT.

Episode 143: The ADAPTABLE Study: Patient-Centered Aspirin 06.04.2022 13:45

C. Michael Gibson discusses aspirin dosing and long-term effectivness with Schuyler Jones and Greg Merritt.

Episode 142: ISCHEMIA: Complete Revascularization and QoL 23.03.2022 6:38

C. Michael Gibson and Kreton Mavromatis discuss how completeness of revascularization impacts quality of life in stable ischemic heart disease patients.

Episode 141: The STRENGTH Study of Omega-3s 16.03.2022 12:56

C. Michael Gibson and Steven Nissen discuss the link between omega-3 fatty acid levels and MACE in patients with high cardiovascular risk.

Episode 140: The SWISS-APERO Trial 02.03.2022 4:03

C. Michael Gibson and Robert Galea discuss Amulet versus Watchman for LAA closure.

Episode 139: The 2021 ESC HF Guidelines 09.02.2022 11:15

C. Michael Gibson and Carolyn Lam discuss key updates to the European heart failure guidelines and how best to initiate medications to optimize outcomes.

Episode 138: The ATLANTIS Trial: DOACs in TAVI? 02.02.2022 14:54

C. Michael Gibson, Jean-Philippe Collet, and Gilles Montalescot and discuss apixiban after TAVI in the Atlantis trial.

Episode 137: Early Intrepid TMVR Results 12.01.2022 6:10

C. Michael Gibson and Firas Zahr discuss 30-day outcomes following transfemoral transseptal TMVR.

Episode 136: Two DCBs vs POBA in Coronary In-Stent Restenosis 05.01.2022 6:13

C. Michael Gibson and Bruno Scheller discuss 1-year outcomes of two parallel RCTs.

Episode 135: The ULTIMATE Trial 22.12.2021 5:52

Junjie Zhang and C. Michael Gibson discuss 3-year outcomes after IVUS- versus angiography-guided DES implantation.

Episode 134: The PROSPECT ABSORB Trial 08.12.2021 12:47

Gregg Stone and C. Michael Gibson discuss a randomized trial examining interventional treatment of vulnerable plaques.

Episode 133: The COBRA-REDUCE Trial 02.12.2021 9:25

Robert Byrne and C. Michael Gibson discuss a randomized trial of a thromboresistant Polyzene F-coated stent with 14-day DAPT in high-bleeding-risk patients.

Episode 132: The RIVER Trial 10.11.2021 8:58

Otavio Berwanger and C. Michael Gibson discuss rivaroxaban versus warfarin in patients with bioprosthetic mitral valves and atrial fibrillation or flutter.

Episode 131: The SCOPE II Trial 03.11.2021 10:04

Corrado Tamburino and C. Michael Gibson discuss a randomized trial of two self-expanding TAVR bioprostheses.